albuterol has been researched along with Bright Disease in 2 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, P | 1 |
| Kumar, V | 1 |
| Dubey, NK | 1 |
| Mahesh, K | 1 |
| Plotkin, VIa | 1 |
| Burmak, IuG | 1 |
2 other studies available for albuterol and Bright Disease
| Article | Year |
|---|---|
Nebulised salbutamol: an antidote for beta blockers.
Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Al | 1999 |
[The role of pharmacological tests in detecting disorders in the bronchial patency and bronchial reactivity of patients with chronic glomerulonephritis].
Topics: Acetylcholine; Adolescent; Adult; Albuterol; Bronchi; Bronchial Hyperreactivity; Bronchial Provocati | 1992 |